Hims & Hers Health, Inc. Class A Common Stock · Transaction Aug 4, 2025 · Filed Sep 12, 2025 · $1,001 to $15,000
Hims & Hers Health, Inc.
Follow $HIMS
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $HIMS by emailVeridion Score
BETALOW CONF · 6 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is HIMS moving today?
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
HIMS overview
Related filings and maps
Congress activity in HIMS
HIMS contract awards, year to date.
Public federal awards linked to this ticker.
HIMS lobbying filings, year to date.
Registered lobbying filings matched to Hims & Hers Health, Inc..